MaxCyte (NASDAQ:MXCT) reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
MaxCyte reported in-line EPS of $-0.08 versus an estimate of $-0.08.
Revenue was up $2.50 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.03 which was followed by a 0.62% drop in the share price the next day.
Here's a look at MaxCyte's past performance:
| Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.07 | -0.05 | -0.05 | -0.05 |
| EPS Actual | -0.04 | -0.05 | -0.03 | -0.05 |
| Revenue Estimate | 8.46M | 9.45M | 7.37M | 5.95M |
| Revenue Actual | 11.59M | 10.15M | 10.14M | 7.11M |
To track all earnings releases for MaxCyte visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
